Document is current
Any future updates will be listed below
-
Authors
Grandke, Friederike https://orcid.org/0000-0001-6185-1472
Fehlmann, Tobias
Kern, Fabian https://orcid.org/0000-0002-8223-3750
Gate, David M. https://orcid.org/0000-0003-0481-9657
Wolff, Tobias William https://orcid.org/0009-0002-5717-2666
Leventhal, Olivia
Channappa, Divya
Hirsch, Pascal https://orcid.org/0000-0003-4152-9931
Wilson, Edward N. https://orcid.org/0000-0003-0640-5247
Meese, Eckart
Liu, Chuanyu
Shi, Quan
Flotho, Matthias https://orcid.org/0009-0006-4374-0801
Li, Yongping
Chen, Cynthia
Yu, Yeya
Xu, Jiangshan
Junkin, Michael
Wang, Zhifeng
Wu, Tao
Liu, Longqi
Hou, Yong
Andreasson, Katrin I. https://orcid.org/0000-0001-8391-4155
Gansen, Jenny S.
Mass, Elvira https://orcid.org/0000-0003-2318-2356
Poston, Kathleen https://orcid.org/0000-0003-3424-7143
Wyss-Coray, Tony https://orcid.org/0000-0001-5893-0831
Keller, Andreas https://orcid.org/0000-0002-5361-0895
-
Funding
Funding for this research was provided by:
Michael J. Fox Foundation for Parkinson's Research (14446, 17047 (subc. 125491594), MJFF-021418)
Deutsche Forschungsgemeinschaft (466168626)
- License Information
-
More Information
Article History
Received: 17 June 2024
Accepted: 29 January 2025
First Online: 25 February 2025
Competing interests
: A.K. was advisor of the company Firalis, researching RNA-based biomarkers for AD, while preparing the manuscript. C.L., Q.S., Y.L., C.C., Y.Y., J.X., M.J., Z.W., T.W., L.L., and Y.H. work for the company MGI group while working on the project. The remaining authors declare no competing interests.
